Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice (Q25257729)

6 July 2017

title

Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice (English)

1 reference

6 July 2017

7

Claudia Lanari

1 reference

6 July 2017

6

Alfredo Molinolo

1 reference

6 July 2017

Caroline A Lamb

1

1 reference

6 July 2017

Luisa A Helguero

2

1 reference

6 July 2017

Sebastián Giulianelli

3

1 reference

6 July 2017

Rocío Soldati

4

1 reference

6 July 2017

Silvia I Vanzulli

5

1 reference

6 July 2017

language of work or name

English

0 references

publication date

9 November 2005

1 reference

6 July 2017

published in

Breast Cancer Research

1 reference

6 July 2017

volume

7

1 reference

6 July 2017

issue

6

1 reference

6 July 2017

page(s)

R1111-21

1 reference

Protein measurement with the Folin phenol reagent

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Progesterone receptors--animal models and cell signalling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Breast cancer and hormone-replacement therapy in the Million Women Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Antisense oligonucleotides for cancer therapy-an overview

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Antisense targets to enhance hormone and cytotoxic therapies in advanced prostate cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

The role of mitogen-activated protein (MAP) kinase in breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Antisense therapy in cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

MDM2 oncogene as a target for cancer therapy: An antisense approach

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Mouse mammary tumors induced by medroxyprogesterone acetate: immunohistochemistry and hormonal receptors

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410760

Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors.

31 May 2018

1 reference

Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment

21 January 2018

1 reference

Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma

21 January 2018

1 reference

Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone recepto

21 January 2018

1 reference

Breast cancer and hormone-replacement therapy: the Million Women Study

21 January 2018

1 reference

Tumor regression by combination antisense therapy against Plk1 and Bcl-2

21 January 2018

1 reference

12 December 2020

Estrogenic effects of the antiprogestin onapristone (ZK98.299) in the rodent uterus

1 reference

12 December 2020

Effect of sialoadenectomy on medroxyprogesterone-acetate-induced mammary carcinogenesis in BALB/c mice. Correlation between histology and epidermal-growth-factor receptor content

1 reference

12 December 2020

Fertility control in wild mice after feeding with RU486 or methyl testosterone

1 reference

12 December 2020

Oestrogen action in the endometrium and oviduct of rhesus monkeys during RU486 treatment

1 reference

12 December 2020

Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma

1 reference

12 December 2020

Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression

1 reference

12 December 2020

Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice

1 reference

12 December 2020

Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice

1 reference

12 December 2020

[Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors]

1 reference

12 December 2020

Modulation of oestrogenic effects by progesterone antagonists in the rat uterus

1 reference

12 December 2020

Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function

1 reference

12 December 2020

Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast

1 reference

12 December 2020

Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation

1 reference

12 December 2020

Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR1345

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference

6 July 2017

1 reference